Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle

被引：0
|
作者：
Arianna Pacchiarotti
Cesare Aragona
Renzo Gaglione
Helmy Selman
机构：
[1] La Sapienza University,
[2] Praxi Provita,undefined
[3] Ospedale SS Immacolata,undefined
[4] Praxi Provata Centro Fertilità,undefined
[5] Perugia University,undefined
来源：
Journal of Assisted Reproduction and Genetics | 2007年 / 24卷
关键词：
Embryo; Oocyte; Ovarian stimulation; Recombinant human FSH; Urinary human FSH;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：400 / 405
页数：5
相关论文
共 50 条
  • [1] Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle
    Pacchiarotti, Arianna
    Aragona, Cesare
    Gaglione, Renzo
    Selman, Helmy
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2007, 24 (09) : 400 - 405
  • [2] Efficacy of recombinant follicle-stimulating hormone
    Quinton, R
    Bouloux, PMG
    Illingworth, JM
    Martineau, I
    Loumaye, E
    FERTILITY AND STERILITY, 1996, 66 (01) : 164 - 164
  • [3] The use of Recombinant Luteinizing Hormone in Addition to Recombinant Follicle-stimulating Hormone in Ovarian Stimulation with the GnRH-antagonist Protocol
    Baruffi, Ricardo L. R.
    Mauri, Ana L.
    Petersen, Claudia G.
    Felipe, Valeria
    Martins, Anice M. C.
    Cornicelli, Joao
    Cavagna, Mario
    Oliveira, Joao B. A.
    Franco, Jose G., Jr.
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2006, 10 (04): : 9 - 16
  • [4] Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome
    Bosch, E
    Escudero, E
    Crespo, J
    Simón, C
    Remohí, J
    Pellicer, A
    FERTILITY AND STERILITY, 2005, 84 (05) : 1529 - 1532
  • [5] Controlled ovarian stimulation with recombinant follicle-stimulating hormone provides better outcomes than urinary gonadotropins for patients undergoing assisted reproductive technologies
    Scheiber, MD
    Behnke, EJ
    Awadalla, SG
    FERTILITY AND STERILITY, 2001, 76 (03) : S235 - S235
  • [6] The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
    Yang, Chunxia
    Dong, Naijun
    Li, Feng
    Ji, Yurong
    Pan, Yu
    She, Hong
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [7] The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
    Chunxia Yang
    Naijun Dong
    Feng Li
    Yurong Ji
    Yu Pan
    Hong She
    Journal of Ovarian Research, 15
  • [8] Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with GonadotropinReleasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?
    Ramachandran, Amar
    Jamdade, Kshitj
    Kumar, Pratap
    Adiga, Satsh Kumar
    Bliar, Rajeshwari G.
    Ferrao, Sinatra R.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (01) : 90 - 92
  • [9] Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial
    Vuong, T. N. L.
    Phung, H. T.
    Ho, M. T.
    HUMAN REPRODUCTION, 2015, 30 (05) : 1188 - 1195
  • [10] Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles
    Mochtar, Monique H.
    Danhof, Nora A.
    Ayeleke, Reuben Olugbenga
    van der Veen, Fulco
    van Wely, Madelon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (05):
12345